Sciegen Pharmaceuticals Inc: Drug Recall
Recall #D-0354-2023 · 02/17/2023
Class III: Low Risk
Recall Details
- Recall Number
- D-0354-2023
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Sciegen Pharmaceuticals Inc
- Status
- Terminated
- Date Initiated
- 02/17/2023
- Location
- Hauppauge, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,392 bottles
Reason for Recall
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
Product Description
Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.
Distribution Pattern
Nationwide in the USA and Puerto Rico
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.